Renzoku Biologics Inc. was established as a CDMO dedicated to leading the next generation of biopharmaceutical manufacturing, with a mission to contribute to global health and healthcare through innovation in biopharmaceutical manufacturing.
By integrating advanced manufacturing technologies, including continuous manufacturing, to realize “Advanced Biomanufacturing Factory,” we aim to revolutionize the manufacturing of antibody drugs. Through a wide range of services—from CMC development strategy planning to the manufacturing of investigational and commercial products—we strive to become a trusted partner for pharmaceutical and biotech companies both in Japan and overseas, enabling the rapid delivery of valuable medicines to patients with high quality and at low cost. We are passionate to contribute to the development of the pharmaceutical industry and the health of patients worldwide.